BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9773436)

  • 1. Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin.
    Knapp JS
    Sex Transm Dis; 1998 Sep; 25(8):425-6. PubMed ID: 9773436
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    JAMA; 1994 Jun; 271(22):1733-4. PubMed ID: 8196105
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone-resistant Neisseria gonorrhoeae in Hong Kong.
    Kam KM; Wong PW; Cheung MM; Ho NK; Lo KK
    Sex Transm Dis; 1996; 23(2):103-8. PubMed ID: 8919735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First isolate of a Neisseria gonorrhoeae strain associated with an ofloxacin treatment failure in Spain: case report.
    Otero L; Alcala B; Varela JA; Miguel MD; Vazquez JA; Vazquez F
    Sex Transm Dis; 2001 Oct; 28(10):576-8. PubMed ID: 11689756
    [No Abstract]   [Full Text] [Related]  

  • 6. Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
    Coughlan EP; Franklin RA
    N Z Med J; 1996 Mar; 109(1017):82. PubMed ID: 8606827
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
    Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
    Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of quinolone-resistant Neisseria gonorrhoeae.
    Kam KM; Wong PW; Cheung MM; Ho NK
    J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh.
    Rahman M; Alam A; Nessa K; Nahar S; Dutta DK; Yasmin L; Monira S; Sultan Z; Khan SA; Albert MJ
    Clin Infect Dis; 2001 Mar; 32(6):884-9. PubMed ID: 11247712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone resistance in Neisseria gonorrhoeae.
    Knapp JS; Fox KK; Trees DL; Whittington WL
    Emerg Infect Dis; 1997; 3(1):33-9. PubMed ID: 9126442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gonococcus: the disturbing development of strains resistant to ciprofloxacin].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(49):250. PubMed ID: 16493970
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.
    Ringuette L; Trudeau T; Turcotte P; Yeung K; Rémis R; Perron L; Le Corre I
    Can Commun Dis Rep; 1996 Aug; 22(15):121-4; discussion 124-5. PubMed ID: 8791859
    [No Abstract]   [Full Text] [Related]  

  • 13. From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    JAMA; 2000 Oct; 284(15):1917-9. PubMed ID: 11183745
    [No Abstract]   [Full Text] [Related]  

  • 14. Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
    Carlyn CJ; Doyle LJ; Knapp CC; Ludwig MD; Washington JA
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1606-8. PubMed ID: 7492114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
    Dan M; Poch F; Sheinberg B
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1671-3. PubMed ID: 12019074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
    Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
    Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba.
    Llanes R; Sosa J; Guzmán D; Gutiérrez Y; Llop A; Ricardo O
    Sex Transm Dis; 2001 Feb; 28(2):82-3. PubMed ID: 11234790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K; Faegri A
    APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelines.
    Berman SM; Moran JS; Wang SA; Workowski KA
    Sex Transm Dis; 2003 Jun; 30(6):528-9; author reply 530. PubMed ID: 12782957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.